Active compounds within FAHF-2, such as berberine, palmatine, and jatrorrhizine, have demonstrated significant inhibitory effects on IgE production and mast cell signaling pathways, including the decrease in phosphorylated Syk, highlighting their therapeutic potential in allergy management. Here, SYK is linked to allergic disease.